News

Dr. Nathan Price promoted to professor

Dr. Nathan Price has been promoted to full professor. He started at ISB as an associate professor in the fall of 2011. Dr. Price also serves as the associate director of ISB and co-PI of the 100K Wellness Project. Congratulations! ISB staff gathered to toast Dr. Price on March 26, 2015:

Dr. Nitin Baliga, Director of ISB, shares a few words about Dr. Nathan Price, who has just been promoted to full professor.

Dr. Nitin Baliga, Director of ISB, shares a few words about Dr. Nathan Price, who has just been promoted to full professor.

Dr. Nathan Price, who has just been promoted to full professor, delivers a few words of thanks. March 26, 2015

Dr. Nathan Price, who has just been promoted to full professor, delivers a few words of thanks. March 26, 2015

Dr. Nathan Price receives applause from his mentor Dr. Lee Hood (foreground). March 26, 2015

Dr. Nathan Price receives applause from his mentor Dr. Lee Hood (foreground). March 26, 2015

From left to right: Dr. Lee Hood, Dr. Nathan Price, Dr. Nitin Baliga. March 26, 2015

From left to right: Dr. Lee Hood, Dr. Nathan Price, Dr. Nitin Baliga. March 26, 2015

Congratulations to Dr. Nathan Price, who has been promoted to full professor. March 26, 2015

Congratulations to Dr. Nathan Price, who has been promoted to full professor. March 26, 2015

Recent Articles

  • Bringing DNA Sequencing to the High School Classroom

    Christopher Lausted and Dr. Danielle Vermaak were featured guests of an ISB Research Roundtable presentation. The husband-and-wife team detailed the planning and rollout of a DNA sequencing curriculum project that was tested in Vermaak’s Lincoln High School science classroom in Seattle.

  • Risk Factors for Severe COVID-19 in Hospitalized Adults Differ by Age

    A just-published study provides new information about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die. The ISB-led work shows that vital signs and lab results at the time of hospital admission are the most accurate predictors of disease severity, more so than comorbidities and demographics.

  • Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

    Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.